Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
F5
FFIV
$21.8B
| $43.7M | 0.08% |
363,419
-47,368
| -12% | -$5.82M |
|
302
NNN REIT
NNN
$8.8B
| $43.6M | 0.08% |
1,246,184
+929,669
| +294% | +$35.6M |
|
303
Magna International
MGA
$19.5B
| $43.6M | 0.08% |
776,789
+119,905
| +18% | +$6.67M |
|
304
MetLife
MET
$60B
| $43.5M | 0.08% |
872,680
+489,353
| +128% | +$23.2M |
|
305
Insulet
PODD
$10.3B
| $43.5M | 0.08% |
1,403,357
-26,726
| -2% | -$788K |
|
|
SEM
306
DELISTED
Select Medical
SEM
| $43.5M | 0.08% |
4,981,712
+3,213,408
| +182% | +$27M |
|
307
T. Rowe Price
TROW
$23.8B
| $43.1M | 0.08% |
554,035
+539,208
| +3,637% | +$43.5M |
|
308
Petrobras Class A
PBR.A
$111B
| $43M | 0.08% |
5,270,923
+3,412,606
| +184% | +$28.6M |
|
309
East-West Bancorp
EWBC
$17.8B
| $42.6M | 0.08% |
+949,952
| New | +$40.7M |
|
310
TIM SA
TIMB
$8.52B
| $42.5M | 0.08% |
2,599,453
+1,191,417
| +85% | +$19M |
|
311
Darling Ingredients
DAR
$10.4B
| $42.5M | 0.08% |
2,900,688
+2,643,270
| +1,027% | +$39M |
|
|
UCB
312
United Community Banks
UCB
$4.29B
| $42.3M | 0.08% |
2,025,760
+262,400
| +15% | +$5.04M |
|
313
Intuitive Surgical
ISRG
$134B
| $42.2M | 0.08% |
784,161
-956,817
| -55% | -$53.5M |
|
|
JNS
314
DELISTED
Janus Capital Group Inc
JNS
| $41.9M | 0.08% |
2,446,450
+1,347,334
| +123% | +$24.1M |
|
315
Regency Centers
REG
$13.9B
| $41.6M | 0.08% |
706,170
+353,881
| +100% | +$22.6M |
|
316
Cooper Companies
COO
$14.9B
| $41.6M | 0.08% |
933,964
+149,892
| +19% | +$6.75M |
|
317
Merck
MRK
$376B
| $41.5M | 0.08% |
763,961
-654,342
| -46% | -$36.7M |
|
318
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $41.4M | 0.08% |
1,998,906
+1,111,962
| +125% | +$23.7M |
|
319
NetEase
NTES
$82.1B
| $41.3M | 0.08% |
1,424,610
+1,315,605
| +1,207% | +$35.1M |
|
320
Chevron
CVX
$403B
| $41M | 0.08% |
424,520
+394,669
| +1,322% | +$41.4M |
|
321
Gen Digital
GEN
$17.3B
| $40.7M | 0.08% |
1,751,644
-468,336
| -21% | -$11.4M |
|
322
Analog Devices
ADI
$182B
| $40.6M | 0.08% |
632,342
+415,333
| +191% | +$26.9M |
|
|
LGF
323
DELISTED
Lions Gate Entertainment
LGF
| $40.6M | 0.08% |
1,094,970
+417,616
| +62% | +$13.9M |
|
324
Lennar Class A
LEN
$21B
| $40.4M | 0.08% |
+832,523
| New | +$38.3M |
|
325
Baidu
BIDU
$31.6B
| $40.4M | 0.08% |
203,155
-67,149
| -25% | -$13.7M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.